The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration
Many pathological conditions are associated with phosphatidylinositol 3-kinase (PI3K) dysfunction, providing an incentive for the study of the effects of PI3K modulation in different aspects of diabetes, cancer, and aging. The PI3K/AKT/mTOR pathway is a key transducer of brain metabolic and mitogeni...
Saved in:
Main Authors: | David Heras-Sandoval (Author), Evangelina Avila-Muñoz (Author), Clorinda Arias (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration
by: Chiara Lanzillotta, et al.
Published: (2020) -
mTOR signaling cascade in psoriatic disease: Double kinase mtor inhibitor a novel therapeutic target
by: Smriti K Raychaudhuri, et al.
Published: (2014) -
Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice
by: Nada El-Megiri, et al.
Published: (2022) -
Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
by: Shraddha Parate, et al.
Published: (2021) -
mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases
by: Yipin Wang, et al.
Published: (2022)